Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
Titel:
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
Auteur:
Lynch, Kate D. Chapman, Roger W. Keshav, Satish Montano-Loza, Aldo J. Mason, Andrew L. Kremer, Andreas E. Vetter, Marcel de Krijger, Manon Ponsioen, Cyriel Y. Trivedi, Palak Hirschfield, Gideon Schramm, Christoph Liu, Chung Heng Bowlus, Christopher L. Estes, Derek J. Pratt, Daniel Hedin, Charlotte Bergquist, Annika de Vries, Annemarie C. van der Woude, C. Janneke Yu, Lei Assis, David N. Boyer, James Ytting, Henriette Hallibasic, Emina Trauner, Michael Marschall, Hanns-Ulrich Daretti, Luigi M. Marzioni, Marco Yimam, Kidist K. Perin, Nicola Floreani, Annarosa Beretta-Piccoli, Benedetta Terziroli Rogers, Jennifer K. Levy, Cynthia